A03*Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)
N. Normanno,Anna Maria Rachiglio,M. Lambiase,Francesca Fenizia,A. Iannaccone,N. Chicchinelli,Alessandro Morabito,A. Montanino,Gaetano Rocco,Domenico Galetta, E.S. Montagna,Lucio Crinò,V. Ludovini,Bruno Vincenzi,E. Barletta,Carmine Pinto,F. Ferraù,Gerardo Botti,Maria Carmela Piccirillo,F. Perrone Annals of Oncology(2016)
AI 理解论文
溯源树
样例